Choosing a Compounding Pharmacy Partner: What to Check

People searching for the best tirzepatide compounding pharmacy online are usually asking a narrower question: how do I know the pharmacy behind my telehealth program is legitimate? You rarely choose the pharmacy directly; your telehealth provider does. But you can, and should, check it. This guide explains the two kinds of compounders in plain terms, shows how to verify a pharmacy license in a few minutes, summarizes FDA’s current position on compounded GLP-1 medications, and lists what a telehealth provider should tell you. Regulatory details were checked on October 30, 2026.

Why the pharmacy matters

A compounded medication is prepared by a pharmacy rather than mass-produced by a drug manufacturer. Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or quality. That puts more weight on the pharmacy’s own licensing, practices, and oversight. FDA’s advice to patients is to get a prescription and fill it at a state-licensed pharmacy, and it lists unfamiliar pharmacy names among the warning signs for online GLP-1 offers.

503A vs. 503B, in plain terms

Federal law describes two pathways for compounding human drugs, named after sections of the Food, Drug, and Cosmetic Act.

	503A pharmacy	503B outsourcing facility
What it is	A state-licensed pharmacy (or physician) compounding for individual patients	A facility registered with FDA as an outsourcing facility
Prescriptions	Must compound based on a valid, patient-specific prescription	May compound for individual prescriptions or for office stock ordered by providers
Manufacturing standards	Exempt from federal current good manufacturing practice (CGMP) requirements if it meets 503A conditions; follows state pharmacy rules	Must follow CGMP requirements
Primary oversight	State board of pharmacy	FDA, which inspects on a risk-based schedule; state licensure may also apply
Reporting	Governed mainly by state requirements	Must report adverse events and certain product information to FDA

Neither label alone tells you a specific pharmacy is a good one. A 503B facility operates under federal manufacturing standards, but as explained below, current FDA policy sharply limits what outsourcing facilities can do with GLP-1 ingredients. For that reason, a compounded GLP-1 prescription written for you as an individual patient is generally filled under the 503A pathway.

What FDA says about compounded GLP-1s right now

The shortages are over

FDA determined that the tirzepatide injection shortage was resolved in December 2024 and the semaglutide injection shortage in February 2025. The temporary flexibility that allowed broad compounding during the shortages ended in 2025 for both 503A pharmacies and 503B outsourcing facilities.

503A pharmacies: individual prescriptions only, with limits on copies

A 503A pharmacy may compound for an individual patient based on a prescription. It may not compound drugs that are “essentially copies” of commercially available approved drugs regularly or in inordinate amounts. FDA generally treats a compounded drug as an essentially copy if its active ingredient matches a commercially available approved product, its strength is the same, similar, or easily substitutable, and the approved product can be used by the same route. A prescriber can document a clinically significant difference for a specific patient.

503B outsourcing facilities: generally unable to compound from bulk

Outsourcing facilities may compound from bulk drug substances only if the substance is on FDA’s 503B bulks list or the drug is in shortage. FDA states that tirzepatide and semaglutide are currently on neither list, and in April 2026 FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list.

Salt forms are a separate problem

FDA has said that salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from those in approved drugs, and that it is not aware of any lawful basis for using them in compounding. If a program or pharmacy lists a salt form on its label, ask about it.

More restrictions may be coming

In February 2026 FDA announced its intent to restrict GLP-1 active ingredients used in non-approved compounded drugs and to address misleading marketing. FDA has also said companies may not describe compounded products as generic versions of, or identical to, approved drugs, or as clinically proven. Expect this area to keep changing; check FDA’s pages for the latest.

How to verify a pharmacy license in a few minutes

1. Get the pharmacy’s legal name and address. Ask your telehealth provider, or look on the prescription label once it arrives.
2. Find your state board of pharmacy. FDA’s BeSafeRx page “Locate a State-Licensed Online Pharmacy” links to the license lookup for every state, D.C., and U.S. territories.
3. Search the license. Confirm the pharmacy is licensed to dispense to patients in your state, not only in the state where it is located. Out-of-state pharmacies shipping to you generally need a nonresident license from your state. FDA’s guidance is that if the pharmacy is not listed, you should not use it.
4. Check status and discipline. Make sure the license is active, and look for any posted disciplinary actions.
5. If it’s a 503B facility, check FDA’s list. FDA publishes a list of registered outsourcing facilities.
6. Confirm the basics FDA lists. A safe pharmacy requires a prescription, has a U.S. physical address and phone number, and has a licensed pharmacist available to answer questions.

Third-party verification programs

Two independent programs can add a layer of confidence, though neither replaces a state license check:

• NABP (National Association of Boards of Pharmacy). NABP’s Safe.Pharmacy site lets you look up a website to see whether it is verified, listed on NABP’s Not Recommended List, or not yet reviewed. A web address ending in “.pharmacy” means NABP has verified the site. NABP notes that logos alone are not enough to signal safety.
• LegitScript. LegitScript certifies healthcare merchants, including telemedicine providers and pharmacies, against standards based on applicable law. A genuine seal links to a live status page on legitscript.com, and you can search a site’s status directly in LegitScript’s database. Status can change, so a static seal image is not proof on its own.

What a telehealth provider should disclose

• Whether the medication is FDA-approved or compounded, with FDA’s language that compounded drugs are not FDA-approved.
• The active ingredient and form (and confirmation it is not a salt form FDA has flagged).
• The name of the dispensing pharmacy, or how to obtain it, so you can check the license.
• How the medication is shipped and kept cold, and what to do if it arrives warm.
• Clear dosing and measuring instructions. FDA has reported adverse events tied to dosing errors with compounded injectable GLP-1s.
• Beyond-use dating and storage instructions, including FDA’s advice to discard multi-dose vials within 28 days of first use.
• How to report a side effect or quality problem, to the care team and to FDA’s MedWatch program.

How Elara approaches this

Elara Health and Wellness is a telehealth program, not a pharmacy. Clinical care is provided by OpenLoop Healthcare Partners, PC, whose board-certified physicians decide whether medication is appropriate. If prescribed, the medication is compounded semaglutide (injection or oral) or compounded tirzepatide, and it is shipped as part of the plan. Our verification details are collected on our trust page, and the steps from assessment to first shipment are on how it works. If you are weighing programs on cost as well, see GLP-1 Programs Without Insurance: The True Monthly Cost.

Frequently asked questions

What is the best tirzepatide compounding pharmacy online?

There is no single answer, and you usually do not pick the pharmacy yourself. The useful question is whether the pharmacy your provider uses is licensed in your state, has a clean disciplinary record, and is disclosed to you. Those can be checked through your state board of pharmacy.

Is a 503B pharmacy better than a 503A pharmacy?

503B outsourcing facilities must follow federal manufacturing standards and are inspected by FDA, while 503A pharmacies are overseen mainly by state boards. But FDA states that outsourcing facilities generally cannot currently compound tirzepatide or semaglutide from bulk ingredients, so for patient-specific GLP-1 prescriptions the 503A pathway is the one most programs use.

Is compounded tirzepatide legal?

A state-licensed 503A pharmacy may compound for an individual patient with a valid prescription, subject to FDA’s limits on compounding essentially copies of approved drugs. FDA has announced its intent to further restrict GLP-1 ingredients in compounded drugs, so the rules may change.

How do I check if an online pharmacy is licensed?

Use your state board of pharmacy’s license lookup; FDA’s BeSafeRx site links to every state’s database. Confirm the license is active and covers your state.

Does a LegitScript or NABP seal mean a pharmacy is safe?

These programs review businesses against their standards, which is useful information. But seals can be imitated, so verify status on the program’s own website and still check the state license.

What is a salt form of semaglutide?

Semaglutide sodium and semaglutide acetate are salt forms. FDA says they are different active ingredients from those in approved drugs and that it is not aware of a lawful basis for using them in compounding.

Sources

• FDA: Human Drug Compounding Laws (accessed October 30, 2026)
• FDA: Information for Outsourcing Facilities (accessed October 30, 2026)
• FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (accessed October 30, 2026)
• FDA: FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List (accessed October 30, 2026)
• FDA: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (accessed October 30, 2026)
• FDA: FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs (accessed October 30, 2026)
• FDA BeSafeRx: Locate a State-Licensed Online Pharmacy (links to every state board of pharmacy) (accessed October 30, 2026)
• NABP Safe.Pharmacy: Find Safe Online Pharmacies (accessed October 30, 2026)
• NABP: Safe Pharmacy Resources (accessed October 30, 2026)
• LegitScript: Certification for Telemedicine Providers (accessed October 30, 2026)
• LegitScript: What the Certification Seal Means and How to Verify It (accessed October 30, 2026)

Published by Elara Health and Wellness, which offers its own GLP-1 program; this is not an independent review. Regulatory information was checked on October 30, 2026 and may change. Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness, or quality. All trademarks belong to their respective owners; no affiliation or endorsement is implied. This article is general information, not medical advice.